# Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation

> **NCT05284071** · NA · COMPLETED · sponsor: **Northern Care Alliance NHS Foundation Trust** · enrollment: 13 (actual)

## Conditions studied

- Diabetes type1
- Diabetes type2

## Interventions

- **DEVICE:** Device: Actiste 1.0 and the Companion app with TBL Backend

## Key facts

- **NCT ID:** NCT05284071
- **Lead sponsor:** Northern Care Alliance NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-14
- **Primary completion:** 2022-12-21
- **Final completion:** 2022-12-21
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05284071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05284071, "Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05284071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*